PhRMA

PhRMA Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from PhRMA, Medical and health, 670 Maine Avenue SW Ste. 1000, Washington D.C., DC.

We represent America’s innovative biopharmaceutical research & biotechnology companies, advocating for policies that support the discovery of new medicines and ensure broad patient access to safe, effective treatments.

09/10/2026

Gilead Sciences just opened a new Research Center in Foster City, CA as part of its $32B U.S. investment through 2030.

This will expand on their capabilities in oncology, inflammation and research data science to advance medicines for some of the world’s most challenging diseases.

When biopharmaceutical companies invest in America, patients win.

Watch the video below from when they first broke ground on the new facility last year! 🔽

https://ow.ly/QsYx50ZLWZ8

09/10/2026

Innovation doesn't happen in a vacuum. Strong intellectual property protections give researchers the confidence to collaborate, share breakthroughs and build on each other's work, all while safeguarding the ideas that make new treatments possible.

That collaboration doesn't just speed up discovery. It drives down costs for the entire system. IP protection isn't a barrier to innovation. It's the foundation of it.

https://ow.ly/FhKf50ZLUEE

Innovation was at the forefront of today’s Axios Live event. Leaders joined Axios in Philadelphia to discuss how biophar...
09/09/2026

Innovation was at the forefront of today’s Axios Live event.

Leaders joined Axios in Philadelphia to discuss how biopharmaceutical leadership improves patient outcomes, establishes new career paths and benefits all Americans.

Photo credits: Christopher Cieri for Axios

09/09/2026

Some hospitals and clinics are running up the score on 340B markups, generating billions in profits with no requirement patients benefit.

The 340B program was created to help vulnerable patients access medicines. Today, too many hospitals use it to generate revenue with little accountability for how those profits are spent.

Patients lose. Hospitals win.

It's time to fix 340B.

Learn more: https://ow.ly/rpt550ZLtvo

09/08/2026

When Fred was diagnosed with pulmonary fibrosis, he accepted that there may never be a cure. He accepted the fact that it was now sometimes a struggle just to breathe, stand up and move around his own house.

Then in October 2025, the FDA approved a breakthrough treatment for pulmonary fibrosis. Because Fred lives in the United States, he was able to access this medicine quickly.

Patients in America get new medicines nearly three years faster than patients in other countries.

Tell Washington to keep America in the lead.

https://ow.ly/vXht50ZKJzG

Evergreening + Hopping America's IP system rewards meaningful innovation while preserving generic and biosimilar competi...
09/06/2026

Evergreening + Hopping

America's IP system rewards meaningful innovation while preserving generic and biosimilar competition. New patents protect new inventions, not the original medicine indefinitely. Our latest resources unpack the facts behind claims about "evergreening" and "product hopping."

Read them at https://ow.ly/5PiM50ZJBLe

09/05/2026

MFN price controls are often framed as a simple fix to drug pricing. The reality is more complicated.

Independent analyses project that more than $500 billion in planned manufacturing and infrastructure investment could be at risk, along with 1.5 million jobs nationwide under a broad MFN policy. Additionally, public pension funds, which help secure the retirement of 36 million Americans, could lose $46 billion annually.

Policymakers must reject MFN and protect the innovative ecosystem patients in the U.S. rely on.

https://ow.ly/Jue550ZJBtq

09/04/2026

Steve Ubl joined The Deciders Podcast with Brody Mullins and Lisa Camooso Miller to discuss why medical innovation hits so close to home.

As the parent of a son with type 1 diabetes, Steve has seen firsthand what's at stake in the search for new medicines and treatments. Patients and families are counting on the next wave of medical progress.

Protecting the innovation ecosystem isn't just a policy. For many families, it’s essential.

Address

670 Maine Avenue SW Ste. 1000
Washington D.C., DC
20024

Telephone

+12028353400

Website

Alerts

Be the first to know and let us send you an email when PhRMA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to PhRMA:

Shortcuts

Featured

Share

Category